Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection.

Epithelial Cells Influenza A Virus Models N-Acetylneuraminic Acid Swine

Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 05 02 2024
revised: 09 04 2024
accepted: 18 04 2024
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 28 4 2024
Statut: aheadofprint

Résumé

We established primary porcine nasal, tracheal, and bronchial epithelial cells that recapitulate the physical and functional properties of the respiratory tract and have the ability to fully differentiate. Trans-well cultures demonstrated increased transepithelial electrical resistance over time the presence of tight junctions as demonstrated by immunohistochemistry. The nasal, tracheal, and bronchial epithelial cells developed cilia, secreted mucus, and expressed sialic acids on surface glycoproteins, the latter which are required for influenza A virus infection. Swine influenza viruses were shown to replicate efficiently in the primary epithelial cell cultures, supporting the use of these culture models to assess swine influenza and other virus infection. Primary porcine nasal, tracheal, and bronchial epithelial cell culture models enable assessment of emerging and novel influenza viruses for pandemic potential as well as mechanistic studies to understand mechanisms of infection, reassortment, and generation of novel virus. As swine are susceptible to infection with multiple viral and bacterial respiratory pathogens, these primary airway cell models may enable study of the cellular response to infection by pathogens associated with Porcine Respiratory Disease Complex.

Identifiants

pubmed: 38679164
pii: S0166-0934(24)00067-3
doi: 10.1016/j.jviromet.2024.114943
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114943

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Declaration of Competing Interest The authors declare no conflicts of interest

Auteurs

Madelyn Krunkosky (M)

Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States; Department of Infectious Diseases, University of Georgia, Athens, GA, United States; Emory-UGA Centers of Excellence for Influenza Research and Surveillance (CEIRS), Athens, GA, United States.

Thomas M Krunkosky (TM)

Department of Biomedical Sciences, University of Georgia, Athens, GA, United States.

Victoria Meliopoulos (V)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States.

Constantinos S Kyriakis (CS)

Emory-UGA Centers of Excellence for Influenza Research and Surveillance (CEIRS), Athens, GA, United States; Department of Pathobiology, Auburn University, Auburn, AL, United States.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States.

S Mark Tompkins (SM)

Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States; Department of Infectious Diseases, University of Georgia, Athens, GA, United States; Emory-UGA Centers of Excellence for Influenza Research and Surveillance (CEIRS), Athens, GA, United States. Electronic address: smt@uga.edu.

Classifications MeSH